Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Heartgard-30 Plus 227 mg Tablet (Chewable) is a Health Canada–registered veterinary drug (DIN 01909991) held by Boehringer Ingelheim Animal Health Canada Inc., containing Pyrantel (Pyrantel Pamoate). Health Canada lists its status as Marketed (status date 16 Aug 2019). Nexara Health has matched 106 registrations of Pyrantel (Pyrantel Pamoate) across 9 other regulated markets.

Health Canada registration

DIN01909991
Brand nameHeartgard-30 Plus
Active ingredientPyrantel (Pyrantel Pamoate)
Strength227 mg
Dosage formTablet (Chewable)
RouteOral
CompanyBoehringer Ingelheim Animal Health Canada Inc.
StatusMarketed — 16 Aug 2019
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Pyrantel (Pyrantel Pamoate) registered in other markets

106 registrations of the same molecule in 9 national registries outside Canada (first 32 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
AustraliaAnthel 125AfTablet 125 mg (as embonate)GEPBS
AustraliaAnthel 250AfTablet 250 mg (as embonate)GEPBS
AustriaCombantrin 250 mg Kautabl.—4Stgreen boxeEKO (Erstattungskodex)
AustriaCombantrin orale Susp.—10mlgreen boxeEKO (Erstattungskodex)
IcelandNematel Vet.Le Vet Beheer B.V.439 mg/gpasta0Lyfjastofnun lyfjaverdskra
MACombantrin—125 MGSuspension BuvablePCNOPS liste des medicaments
MACombantrin—125 MGComprimePCNOPS liste des medicaments
MACombantrin—250 MGComprime A CroquerPCNOPS liste des medicaments
MAHelmintox—250 MGComprime Pellicule SecablePCNOPS liste des medicaments
MAHelmintox—125 MGSuspension BuvablePCNOPS liste des medicaments
PolandOwixZakłady Farmaceutyczne POLPHARMA S.A.250 mg/5 mlZawiesina doustnaBezterminoweURPL RPL
PolandOwixZakłady Farmaceutyczne POLPHARMA S.A.250 mgTabletkiBezterminoweURPL RPL
PolandPyrantel-pasta dla kotówVet Planet Sp. z o.o.9,3 g/100 gPasta doustnaBezterminoweURPL RPL
Saudi ArabiaCombantrin 250mg Tab—250InactiveSFDA
TaiwanAnthel 125 TabletsAlphapharm Pty. Ltd.錠劑已註銷TFDA
TaiwanAnthel 250 TabletsAlphapharm Pty. Ltd.錠劑已註銷TFDA
TaiwanAnthelmin Tablets 125mg (Phrantel)尼斯可股份有限公司新莊廠錠劑已註銷TFDA
TaiwanAntiworm Tablets人人化學製藥股份有限公司中壢廠錠劑已註銷TFDA
TaiwanChnpisu Granules (Pyrantel) "Curie"寶齡富錦生技股份有限公司居禮廠內服顆粒劑已註銷TFDA
TaiwanChnpisu Tablets寶齡富錦生技股份有限公司居禮廠錠劑已註銷TFDA
TaiwanCochow Tablets 125mg "W.p." (Pyrantel Pamoate)華盛頓製藥廠股份有限公司錠劑RegisteredTFDA
TaiwanCochow Tablets 175mg "W.P." (Pyrantel pamoate)華盛頓製藥廠股份有限公司錠劑RegisteredTFDA
TurkeyKontil 250 mg 6 TabletHüsnü Arsan İlaçlari A.ş.AktifTITCK
TurkeyKontil 5 mL 250 mg 15 mL SuspansiyonHüsnü Arsan İlaçlari A.ş.AktifTITCK
United StatesCVS Pinworm TreatmentCvs Pharmacy IncSuspensionlistedFDA NDC
United StatesLombrixOpmx LLCTabletlistedFDA NDC
United StatesMebendamaX PinwormPharmadel LLCTabletlistedFDA NDC
United StatesParasitolMenper Distributors Inc.SuspensionlistedFDA NDC
United StatesPinridYyba CorpTabletlistedFDA NDC
United StatesPinridYyba CorpTabletlistedFDA NDC
United StatesPinridYyba CorpTabletlistedFDA NDC
United StatesPinworm MedicineReese Pharmaceutical Co.SuspensionlistedFDA NDC

See every manufacturer of Pyrantel (Pyrantel Pamoate) worldwide →

Regulator price references for Pyrantel (Pyrantel Pamoate)

Published list or reimbursement prices for Pyrantel (Pyrantel Pamoate) presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

CountryProductStrengthPackPriceTypeSourceAs of
AustraliaAnthel 125Tablet 125 mg (as embonate)4.18 AUDex-manufacturerPBS2026-09-08
AustraliaAnthel 250Tablet 250 mg (as embonate)8.36 AUDex-manufacturerPBS2026-09-08
AustriaCombantrin orale Susp.10ml10ml5.15 EURKVP (Kassenverkaufspreis)eEKO (Erstattungskodex)2026-09-03
AustriaCombantrin 250 mg Kautabl.250mg4St8.60 EURKVP (Kassenverkaufspreis)eEKO (Erstattungskodex)2026-09-03
IcelandNematel Vet.439mg/1000mgspr1,280.00 ISKmax wholesaleLyfjastofnun lyfjaverdskra2026-09-02
MAHelmintox250mg1 BOITE 3 COMPRIME18.90 MADPPV (public price)CNOPS liste des medicaments2026-09-05
MACombantrin125mg1 BOITE 6 COMPRIME20.00 MADPPV (public price)CNOPS liste des medicaments2026-09-05
MAHelmintox125mg1 FLACON 15 ML21.35 MADPPV (public price)CNOPS liste des medicaments2026-09-05
MACombantrin125mg1 FLACON 15 ML21.40 MADPPV (public price)CNOPS liste des medicaments2026-09-05
MACombantrin250mg1 BOITE 3 COMPRIME22.10 MADPPV (public price)CNOPS liste des medicaments2026-09-05
Saudi ArabiaCombantrin 250mg Tab250mg5.80 SARpublicSFDA2026-09-01

Marketed Canadian products with the same active ingredient

DINProductCompanyStrengthForm
01909983Heartgard-30 PlusBoehringer Ingelheim Animal Health Canada Inc.114 mgTablet (Chewable)
01909975Heartgard-30 PlusBoehringer Ingelheim Animal Health Canada Inc.57 mgTablet (Chewable)

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Heartgard-30 Plus (DIN 01909991) marketed in Canada?

Yes. Health Canada lists DIN 01909991 as Marketed as of 16 Aug 2019.

Who holds the Canadian licence for this product?

Boehringer Ingelheim Animal Health Canada Inc. is the company of record in the Health Canada Drug Product Database.

Is Pyrantel (Pyrantel Pamoate) registered outside Canada?

Yes — Nexara Health has matched 106 registrations in 9 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 01909991, status date 2019-08-16; national medicine registries: CNOPS liste des medicaments, eEKO (Erstattungskodex), FDA NDC, Lyfjastofnun lyfjaverdskra, PBS, SFDA, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, PBS, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 01909991, status date 2019-08-16; national medicine registries: CNOPS liste des medicaments, eEKO (Erstattungskodex), FDA NDC, Lyfjastofnun lyfjaverdskra, PBS, SFDA, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, PBS, SFDA.

Health Canada Drug Product Database (DPD), DIN 01909991, status date 2019-08-16; national medicine registries: CNOPS liste des medicaments, eEKO (Erstattungskodex), FDA NDC, Lyfjastofnun lyfjaverdskra, PBS, SFDA, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, PBS, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.